Cargando…

A novel prognostic signature for idiopathic pulmonary fibrosis based on five-immune-related genes

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a highly fatal lung disease of unknown etiology with a median survival after diagnosis of only 2–3 years. Its poor prognosis is due to the limited therapy options available as well as the lack of effective prognostic indicators. This study aimed to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qiu, Lingxiao, Gong, Gencheng, Wu, Wenjuan, Li, Nana, Li, Zhaonan, Chen, Shanshan, Li, Ping, Chen, Tengfei, Zhao, Huasi, Hu, Chunling, Fang, Zeming, Wang, Yan, Liu, Hongping, Cui, Panpan, Zhang, Guojun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576669/ https://www.ncbi.nlm.nih.gov/pubmed/34790776 http://dx.doi.org/10.21037/atm-21-4545

Ejemplares similares

Bioinformatic analysis of differentially expressed genes and pathways in idiopathic pulmonary fibrosis
por: Li, Nana, et al.
Publicado: (2021)

Efficacy and safety of pirfenidone in the treatment of idiopathic pulmonary fibrosis patients: a systematic review and meta-analysis of randomised controlled trials
por: Wu, Wenjuan, et al.
Publicado: (2021)

Contribution of Adiponectin/Carnitine Palmityl Transferase 1A-Mediated Fatty Acid Metabolism during the Development of Idiopathic Pulmonary Fibrosis
por: Wu, Wenjuan, et al.
Publicado: (2022)

A potential three-gene-based diagnostic signature for idiopathic pulmonary fibrosis
por: Wu, Yi, et al.
Publicado: (2023)

Analysis of the safety and efficacy of different plasma concentrations of pirfenidone in patients with idiopathic pulmonary fibrosis
por: Li, Hui, et al.
Publicado: (2022)

Inhibition of miR-199a-5p rejuvenates aged mesenchymal stem cells derived from patients with idiopathic pulmonary fibrosis and improves their therapeutic efficacy in experimental pulmonary fibrosis
por: Shi, Linli, et al.
Publicado: (2021)

The Role of Infection in Acute Exacerbation of Idiopathic Pulmonary Fibrosis
por: Weng, Dong, et al.
Publicado: (2019)

Genetic association of telomere length, obesity and tobacoo smoking with idiopathic pulmonary fibrosis risk
por: Wu, Wenjuan, et al.
Publicado: (2023)

Pathway-based detection of idiopathic pulmonary fibrosis at an early stage
por: Zhou, Guojun, et al.
Publicado: (2017)

Long Noncoding RNA RGMB-AS1 Indicates a Poor Prognosis and Modulates Cell Proliferation, Migration and Invasion in Lung Adenocarcinoma
por: Li, Ping, et al.
Publicado: (2016)

CircRNA TADA2A relieves idiopathic pulmonary fibrosis by inhibiting proliferation and activation of fibroblasts
por: Li, Juan, et al.
Publicado: (2020)

An 8-ferroptosis-related genes signature from Bronchoalveolar Lavage Fluid for prognosis in patients with idiopathic pulmonary fibrosis
por: He, Yaowu, et al.
Publicado: (2022)

Clinical Characteristics and Prognosis of Patients With Pulmonary Mucoepidermoid Carcinoma: A SEER-Based Analysis
por: Qiu, Lingxiao, et al.
Publicado: (2021)

Stimulator of Interferon Genes Deficiency in Acute Exacerbation of Idiopathic Pulmonary Fibrosis
por: Qiu, Hui, et al.
Publicado: (2017)

Potential Five-MicroRNA Signature Model for the Prediction of Prognosis in Patients with Wilms Tumor
por: Gong, Yihang, et al.
Publicado: (2019)

An mTOR and DNA-PK dual inhibitor CC-115 hinders non-small cell lung cancer cell growth
por: Chen, Fagui, et al.
Publicado: (2022)

Los increíbles
por: Huasi, Julio
Publicado: (1965)

Matria mía azul ; Asesinaciones ;Comparancias /
por: Huasi, Julio
Publicado: (1983)

Investigation of a Hypoxia-Immune-Related Microenvironment Gene Signature and Prediction Model for Idiopathic Pulmonary Fibrosis
por: Li, Xinyu, et al.
Publicado: (2021)

Baicalein alleviates fibrosis and inflammation in systemic sclerosis by regulating B-cell abnormalities
por: Peng, Bo, et al.
Publicado: (2023)

Quantitative proteomic characterization of lung tissue in idiopathic pulmonary fibrosis
por: Tian, Yaqiong, et al.
Publicado: (2019)

Current therapies for patients with acute exacerbation of idiopathic pulmonary fibrosis
por: Zhu, Li-Li, et al.
Publicado: (2020)

A novel gene signature based on the hub genes of COVID-19 predicts the prognosis of idiopathic pulmonary fibrosis
por: Guo, Run, et al.
Publicado: (2022)

Detecting the Molecular System Signatures of Idiopathic Pulmonary Fibrosis through Integrated Genomic Analysis
por: Gangwar, Indu, et al.
Publicado: (2017)

Integrative analysis of lung molecular signatures reveals key drivers of idiopathic pulmonary fibrosis
por: Kim, Sung Kyoung, et al.
Publicado: (2021)

Identification of Genetic Signature Associated With Aging in Pulmonary Fibrosis
por: Lu, Yanjiao, et al.
Publicado: (2021)

Five EMT-Related Gene Signatures Predict Acute Myeloid Leukemia Patient Outcome
por: Qi, Jing, et al.
Publicado: (2022)

Plasma microRNAs are associated with acute exacerbation in idiopathic pulmonary fibrosis
por: Min, Haiyan, et al.
Publicado: (2016)

Neutrophil-Related Gene Expression Signatures in Idiopathic Pulmonary Fibrosis: Implications for Disease Characteristic and Identification of Diagnostic Hub Genes
por: Lin, Yingying, et al.
Publicado: (2023)

Transcriptomic profiling and longitudinal study reveal the relationship of anti-MDA5 titer and type I IFN signature in MDA5+ dermatomyositis
por: Wang, Yan, et al.
Publicado: (2023)

Five metastasis-related mRNAs signature predicting the survival of patients with liver hepatocellular carcinoma
por: Chen, Chao, et al.
Publicado: (2021)

Identification of common signatures in idiopathic pulmonary fibrosis and lung cancer using gene expression modeling
por: Leng, Dong, et al.
Publicado: (2020)

Identification of the shared genes and immune signatures between systemic lupus erythematosus and idiopathic pulmonary fibrosis
por: Liao, Sheng, et al.
Publicado: (2023)

Idiopathic pulmonary fibrosis
por: Meltzer, Eric B, et al.
Publicado: (2008)

Idiopathic Pulmonary Fibrosis
por: Lynch, Joseph P., et al.
Publicado: (2011)

Mesenchymal stem cells in idiopathic pulmonary fibrosis
por: Li, Xiaohong, et al.
Publicado: (2017)

Comprehensive Analysis of Immune-Related Metabolic Genes in Lung Adenocarcinoma
por: Li, Fangfang, et al.
Publicado: (2022)

Transcriptome Classification Reveals Molecular Subgroups in Idiopathic Pulmonary Fibrosis
por: Liu, Yuxia, et al.
Publicado: (2022)

Critical appraisal of the quality of clinical practice guidelines for idiopathic pulmonary fibrosis
por: Li, Xuanlin, et al.
Publicado: (2020)

CC Chemokines in Idiopathic Pulmonary Fibrosis: Pathogenic Role and Therapeutic Potential
por: Liu, Shanshan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_p0kpskquq6qjl587p83j98dt9j